HST Global is a shell company with no revenue, no operations, and no customers. HST Global was founded with a plan to build a network of wellness centers focused on homeopathic and alternative treatments for late-stage cancer and other life-threatening diseases, but has never executed on this plan. Management states that HST Global is also exploring opportunities to acquire assets or other revenue streams, but none have materialized. The company funds its minimal activities — primarily a $120K/year consulting fee paid to CEO Ron Howell — through loans from related parties. HST Global carries an accumulated deficit of approximately $6M and holds a cash balance of $1,526. The company's auditor has issued a going concern opinion, and management's plan to continue operations depends on raising additional capital through public or private offerings or further loans from officers and directors.